+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neuromyelitis optica and tactile and visual hallucinations in an elderly patient



Neuromyelitis optica and tactile and visual hallucinations in an elderly patient



Age and Ageing (): -



NlmCategory="UNASSIGNED">Although neuromyelitis optica initially described by Eugen Devic in 1897 was considered for many years as a variant of multiple sclerosis, clinical course, more aggressive from the start, progressive towards severe disability and poor visual prognosis, and a different response to treatment, clearly point to a different process. Anti-aquaporin 4 antibodies are a specific biomarker of the entity and, since their discovery, both the number of symptoms and the radiological data about the disease have progressively increased, and the concept of clinical spectrum of neuromyelitis optica has been defined. To our knowledge it is the first reported case of encephalopathy and neuromyelitis optica in elderly patient.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058393049

Download citation: RISBibTeXText

PMID: 27625153

DOI: 10.1093/ageing/afw170


Related references

Neuromyelitis optica and tactile and visual hallucinations in an elderly patient. Age and Ageing 46(1): 156-157, 2018

Functional MRI as a tool for assessing chiasmal visual defect in a patient with neuromyelitis optica. Journal of Neurology, Neurosurgery, and Psychiatry 81(10): 1174-1175, 2010

An unusual chiasmal visual defect in a patient with neuromyelitis optica: case report. Arquivos Brasileiros de Oftalmologia 70(1): 153-155, 2007

Late onset neuromyelitis optica mimicking an acute stroke in an elderly patient. Journal of Neuroimmunology 309: 1-3, 2017

Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder. Internal Medicine 51(7): 809-812, 2012

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133(Pt 2): 349-361, 2010

Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features. Neurologist 20(4): 61-66, 2016

Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder. European Journal of Neurology 24(1): 219-226, 2016

Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Multiple Sclerosis 15(7): 828-833, 2009

The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China. Clinical Neuropharmacology 39(2): 81-87, 2016

Neuromyelitis optica and neuromyelitis optica spectrum disorders: the evaluation of 86 patients followed by Istanbul Bilim University, Department of Neurology. Journal of the Neurological Sciences 357: E296-E297, 2015

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience. Journal of Neurosciences in Rural Practice 6(3): 331-335, 2015

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders. Mediators of Inflammation 2016: 3678152, 2017

Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica. Chinese Medical Journal 125(2): 270-274, 2012

A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran. Iranian Journal of Neurology 14(4): 204-210, 2016